Results 161 to 170 of about 182,211 (308)

Identification of novel paracrine therapeutic targets in peritoneal metastases through integrative proteotranscriptomic analysis of ascites. [PDF]

Mol Cancer
Liu Y, Chong CYL, Wang Y, Xu L, Lim HJ, Tan QX, Hendrikson J, Tan JW, Ng G, Guo W, Wang Y, Huang L, Ge W, Rethineswaran VK, Ong JZL, Quek YE, Ang AJY, Teo F, Chen OW, Rajesh A, Zhang Y, Ko TK, Kannan B, Lim BY, Lee ECY, Guo Z, Lakshmanan V, Shannon NB, Jegannathan N, Joseph CR, Neo ZW, Chong LY, Ng ARH, Lee JJ, Loo LH, Wu Y, Zhang S, Nie L, Zhang Q, Zeng L, Lim TKH, Ng MCH, Lee CJZ, Chang PEJ, Kim-Jun Teh K, Tan HK, Nadarajah R, Yong TT, Wang J, Aggarwal IM, Fong ELS, Wu KZ, So JBY, Yeoh KG, Wong JSM, Seo CJ, Cai M, Chia CS, Teh BT, Tan IB, Yeong J, Chan JY, Guo T, Ong CJ, Singapore Peritoneal Oncology Study (SPOS) Group and Singapore Gastric Cancer Consortium (SGCC).   +64 more
europepmc   +1 more source

Anticarcinogenic and cytotoxic potential of Hemidesmus indicus root extract against Ehrlich Ascites tumor

, 2012
The purpose of the present work was to evaluate anticarcinogenic and cytotoxic potential of Hemidesmus indicus methanolic root extract (HiRe) against Ehrlich Ascites Tumor.
Komal Kumar, J., Zarei, Mahsa
core  

Unexplained ascites [PDF]

Clinical Liver Disease, 2016
Ruben, Hernaez, James P, Hamilton
openaire   +2 more sources

Development and External Validation of a Postoperative Risk Score for Venous Thromboembolism in Epithelial Ovarian Cancer

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Venous thromboembolism (VTE), including deep vein thrombosis and pulmonary embolism, is a major complication in women with epithelial ovarian cancer (EOC). We aimed to develop and externally validate an early postoperative risk score to identify EOC patients at increased risk of VTE after debulking surgery.
Qiu‐Lin Cui, Yu‐Shi He, Xuan‐Hui Wang, Cheng Li, Gang Wang, Ming Chen, Shu‐Min Chen   +6 more
wiley   +1 more source

Highly viscous ascites prompting reconsideration of cardiorenal syndrome in a patient with advanced CKD after TAVI. [PDF]

CEN Case Rep
Yamada K, Koshida T, Abe K, Kobayashi T, Kihara M, Gohda T, Suzuki Y.   +6 more
europepmc   +1 more source

Determinants of Early Renal Function Recovery After TIPS in Patients With Portal Hypertension

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Renal dysfunction frequently occurs in patients with portal hypertension and is linked to unfavorable clinical outcomes. Transjugular intrahepatic portosystemic shunt (TIPS) has the potential to enhance renal perfusion through portal decompression; however, factors predicting early improvement in renal function remain insufficiently defined ...
Meng Jia, Yang Luo, Zhao‐Yang Tan, Xiao‐Ling Zhou, Xi‐You Zhang, Jing‐Ying Sun, Ye Du   +6 more
wiley   +1 more source

Clinical Heterogeneity of Refractory Ascites After Pediatric Liver Transplantation Modulates Allograft Rejection Risk. [PDF]

MedComm (2020)
Wang B, Gao Y, Song J, Pan Q, Zhou A, Liu H, Xiao W, Zhao Z, Yang T, Chen C, Zong Z, Zhou T, Luo Y, Liu Y, Liu Y, Xia Q.   +15 more
europepmc   +1 more source

Chylous Ascites [PDF]

Journal of General Internal Medicine, 2019
Elizabeth, Adler, Cooper, Bloyd, Susan, Wlodarczyk   +2 more
openaire   +2 more sources

Machine Learning Model for Predicting Hepatocellular Carcinoma Development in Patients With Hepatitis B Virus‐Related Cirrhosis Receiving Antiviral Therapy

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Few prediction models have been specifically designed to evaluate the risk of hepatocellular carcinoma (HCC) in patients with chronic hepatitis B and cirrhosis. This study aimed to develop a machine learning‐based prediction model to assess the risk of developing HCC in patients with hepatitis B virus (HBV)‐related cirrhosis undergoing nucleos(
Pao‐Yuan Huang, Heng‐Syu Lin, Cheng‐Yuan Peng, Ruei‐Hau Hsu, Chien‐Hung Chen   +4 more
wiley   +1 more source

Ascites reprograms innate lymphoid immune cells in ovarian cancer by promoting ILC2 enrichment and dysfunctional NK-cell states. [PDF]

J Immunother Cancer
Alashkar Alhamwe B, Alhamdan F, Ponath V, Hoffmann N, Meena C, Fingernagel F, Garn H, Pauk K, Keber C, Denkert C, Reinartz S, Pogge von Strandmann E.   +11 more
europepmc   +1 more source